🔥 Friday 6 February 2026 Fri, 6 Feb 2026

28 Big Stories

Apiam Animal Health Suspended as Adamantem Acquisition Clears Court

Shares of Apiam Animal Health Limited (ASX – AHX) have been suspended from trading following court approval of its acquisition by entities controlled by Adamantem Capital Fund II. This marks a significant ownership change for the animal health company.
6 Feb
Ada Torres
Ada Torres

Nimy Ships High-Grade Gallium Test Material to U.S. for Processing Analysis Under Strategic M2i Partnership

Nimy Resources has dispatched its first shipment of high-grade gallium mineralised test material from Western Australia to the United States, marking a key step in developing a secure Western supply chain for this critical mineral. The collaboration with M2i Global aims to identify optimal processing routes to support U.S. defence and semiconductor industries.
6 Feb
Maxwell Dee
Maxwell Dee

Kalamazoo Raises $4.1M in Oversubscribed SPP to Accelerate Ashburton Gold Project Drilling

Kalamazoo Resources has successfully closed an oversubscribed Share Purchase Plan, raising $4.1 million to fast-track drilling and development at its Ashburton Gold Project. Combined with a recent placement, the company secures $12.1 million to advance exploration and pre-feasibility studies.
6 Feb
Maxwell Dee
Maxwell Dee

Apiam Animal Health Scheme Approved, Shares Suspended on ASX

Apiam Animal Health’s acquisition scheme by Adamantem Capital has been legally approved, leading to the suspension of its shares on the ASX. Key dates for dividend payments and scheme implementation are now set.
6 Feb
Ada Torres
Ada Torres

Brisbane Broncos Forecast 30-40% Profit Surge After Dual Premiership Triumphs

Brisbane Broncos Limited projects a significant profit increase for 2025, driven by premiership wins in both their NRL and NRLW teams and boosted commercial revenues.
6 Feb
Victor Sage
Victor Sage

NSW Court Greenlights Adamantem’s Acquisition of Apiam Animal Health

The Supreme Court of New South Wales has approved the scheme of arrangement for Adamantem Capital Fund II’s acquisition of Apiam Animal Health, marking a pivotal step toward the deal’s completion and the suspension of Apiam shares on the ASX.
6 Feb
Ada Torres
Ada Torres

DPM Metals Extends Chelopech Mine Life to 10 Years with New Reserves and Discoveries

DPM Metals has extended the life of its Chelopech mine in Bulgaria to 2036, supported by a 42% increase in mineral reserves and promising new discoveries. The updated life of mine plan forecasts sustained production of around 160,000 gold equivalent ounces annually.
6 Feb
Maxwell Dee
Maxwell Dee

Cannindah Resources Launches $15M Placement and $2M Share Purchase Plan

Cannindah Resources has announced a two-tranche placement raising approximately $15 million and a concurrent Share Purchase Plan offering eligible shareholders the chance to invest up to $30,000 at a discounted price. The funds will support drilling and exploration at the Mt Cannindah Copper-Gold Project.
6 Feb
Maxwell Dee
Maxwell Dee

Estrella Accelerates Ira Miri Manganese Extraction, Eyes 30,000 Tonne Market Sample

Estrella Resources has ramped up extraction at its Ira Miri manganese project in Timor-Leste, targeting a significant 30,000 tonne market sample as it advances towards commercial production.
6 Feb
Maxwell Dee
Maxwell Dee

Rumble Secures 100% Ownership of Thunderstorm Gold Project with High-Grade Hits

Rumble Resources has completed its full acquisition of the Thunderstorm Gold Project in Western Australia, consolidating control over promising high-grade gold prospects at Gazelle and Pion. A major drilling campaign is set to follow after heritage clearances in early 2026.
6 Feb
Maxwell Dee
Maxwell Dee

WAM Active Raises $51.4M in Discounted Entitlement Offer Amid Strong Demand

WAM Active Limited has launched a $51.4 million pro-rata entitlement offer at a 7.8% discount to the recent share price, alongside a $19.3 million institutional placement to meet strong investor demand. The capital raising aims to bolster the company’s proven Australian equity investment strategy while offering shareholders fully franked dividends on new shares.
6 Feb
Claire Turing
Claire Turing

Lotus Resources Secures A$76 Million to Power Uranium Production Ramp-Up

Lotus Resources has completed a A$76 million placement to bolster its financial position as it accelerates uranium production at the Kayelekera Mine, aiming for steady state output and first shipments in Q2 2026.
6 Feb
Maxwell Dee
Maxwell Dee

Terragen Secures A$7M to Boost R&D and Global Reach Amid Leadership Shift

Terragen Holdings has raised A$7 million through a strategic equity raising to fund scientific research and accelerate global commercialisation, while appointing Dr Michele Allan AO as its new Chair.
6 Feb
Ada Torres
Ada Torres

Rapid Critical Metals Confirms Bonanza-Grade Silver Continuity at Webbs

Rapid Critical Metals has reported additional bonanza-grade silver intercepts from its latest drilling at the Webbs Silver Project, reinforcing the presence of multiple high-grade mineralised structures and promising exploration upside.
6 Feb
Maxwell Dee
Maxwell Dee

Evergold Secures A$5.23M to Ignite Gold Drilling in WA’s Hotspots

Evergold Minerals has raised A$5.23 million to accelerate gold exploration at its Mt Monger and Leonora projects in Western Australia, setting the stage for imminent drilling and resource expansion.
6 Feb
Maxwell Dee
Maxwell Dee

Acusensus Resolves Patent Dispute with Redflex, Issues $10m in Shares

Acusensus Limited has settled its patent litigation with Redflex Traffic Systems, issuing over six million shares and paying US$6 million in cash to resolve the dispute. The agreement clears the way for Acusensus to continue its road safety technology operations unimpeded.
6 Feb
Sophie Babbage
Sophie Babbage

Elixir Energy Advances Lorelle-3 Well Ahead of Key Flow Tests

Elixir Energy has reached 2,320 metres in the Lorelle-3 appraisal well and is preparing to drill the reservoir section targeting the Dunk member of the Tinowon Sandstone, with flow testing planned before mid-2026.
6 Feb
Maxwell Dee
Maxwell Dee

Imricor Advances MRI-Guided Cardiac Tech with FDA Submission of Advantage-MR

Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.
6 Feb
Ada Torres
Ada Torres

HMC Capital Secures $603 Million KKR Backing to Accelerate Energy Transition

HMC Capital has forged a strategic partnership with global investor KKR, securing up to $603 million to expand its Energy Transition Platform focused on battery storage and wind projects. This deal aims to boost Australia’s renewable capacity while enhancing shareholder returns.
6 Feb
Maxwell Dee
Maxwell Dee

News Corp Q2 FY26 – Revenue Climbs 6% Amid Net Income Dip and AI Content Push

News Corporation reported a 6% rise in Q2 FY2026 revenues to $2.36 billion, driven by strong performances in Dow Jones, Digital Real Estate Services, and Book Publishing. Despite a 21% fall in net income due to prior year one-offs, the company is optimistic about AI partnerships and accelerating share buybacks.
6 Feb
Elise Vega
Elise Vega

Charter Hall Retail REIT Doubles Profit, Boosts Convenience Retail Holdings

Charter Hall Retail REIT reported a robust half-year result with statutory profit surging to $240.7 million, driven by portfolio growth and strategic transactions. The REIT also advanced its convenience retail focus and announced a major debt refinancing.
6 Feb
Eva Park
Eva Park

Berkeley Energia Stakes $1.25 Billion Claim Against Spain Over Salamanca Project

Berkeley Energia’s subsidiary has lodged a $1.25 billion arbitration claim against Spain, alleging treaty violations that have stalled its Salamanca uranium project. Despite the dispute, the company remains committed to dialogue and project development.
6 Feb
Maxwell Dee
Maxwell Dee

REA Group Boosts Revenue 5% with AI Push and $200m Share Buy-Back

REA Group Ltd reported a solid 5% revenue increase for H1 FY26, driven by strong buyer demand and strategic AI integration, alongside announcing a $200 million on-market share buy-back.
6 Feb
Sophie Babbage
Sophie Babbage

Immutep Hits 50% Enrolment in Pivotal Lung Cancer Trial

Immutep Limited has reached the halfway mark in enrolling patients for its global Phase III TACTI-004 trial, testing a novel immunotherapy combo in first-line non-small cell lung cancer. The trial remains on track for key milestones this year, signaling steady progress in a critical oncology space.
6 Feb
Ada Torres
Ada Torres